Cargando…

3D-QSAR Design of New Escitalopram Derivatives for the Treatment of Major Depressive Disorders

Antidepressants are psychiatric agents used for the treatment of different types of depression being at present amongst the most commonly prescribed drug, while their effectiveness and adverse effects are the subject of many studies and competing claims. Having studied five QSAR models predicting th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Avram, Speranta, Buiu, Catalin, Duda-Seiman, Daniel M., Duda-Seiman, Corina, Mihailescu, Dan
Formato:	Texto
Lenguaje:	English
Publicado:	Österreichische Apotheker-Verlagsgesellschaft 2010
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3002802/ https://www.ncbi.nlm.nih.gov/pubmed/21179345 http://dx.doi.org/10.3797/scipharm.0912-22

Ejemplares similares

Prevention of Deficit in Neuropsychiatric Disorders through Monitoring of Arsenic and Its Derivatives as Well as Through Bioinformatics and Cheminformatics
por: Avram, Speranta, et al.
Publicado: (2019)

Chemical Structure-Biological Activity Models for Pharmacophores’ 3D-Interactions
por: Putz, Mihai V., et al.
Publicado: (2016)

Introducing Catastrophe-QSAR. Application on Modeling Molecular Mechanisms of Pyridinone Derivative-Type HIV Non-Nucleoside Reverse Transcriptase Inhibitors
por: Putz, Mihai V., et al.
Publicado: (2011)

Design of a Synthetic Long Peptide Vaccine Targeting HPV-16 and -18 Using Immunoinformatic Methods
por: Tîrziu, Alexandru, et al.
Publicado: (2023)

3D-ALMOND-QSAR Models to Predict the Antidepressant Effect of Some Natural Compounds
por: Avram, Speranta, et al.
Publicado: (2021)

Structure–Biological Function Relationship Extended to Mitotic Arrest-Deficient 2-Like Protein Mad2 Native and Mutants-New Opportunity for Genetic Disorder Control
por: Avram, Speranta, et al.
Publicado: (2014)

Chondroitin Sulfate Proteoglycans: Structure-Function Relationship with Implication in Neural Development and Brain Disorders
por: Avram, Speranta, et al.
Publicado: (2014)

Learning the Relationship between the Primary Structure of HIV Envelope Glycoproteins and Neutralization Activity of Particular Antibodies by Using Artificial Neural Networks
por: Buiu, Cătălin, et al.
Publicado: (2016)

Comparative efficacy of escitalopram in the treatment of major depressive disorder
por: Ali, Mazen K, et al.
Publicado: (2011)

Cost-effectiveness evaluation of escitalopram in major depressive disorder in Italy
por: Mencacci, Claudio, et al.
Publicado: (2013)

Antimicrobial Activities of Chitosan Derivatives
por: Ardean, Cristina, et al.
Publicado: (2021)

Reproducibility of the Efficacy of Escitalopram in Patients with Major Depression Who Had Previously Remitted with Escitalopram
por: Yoshimura, Reiji, et al.
Publicado: (2021)

COVID-19 Related Myocarditis and Myositis in a Patient with Undiagnosed Antisynthetase Syndrome
por: Duda-Seiman, Daniel, et al.
Publicado: (2022)

Antimicrobial Perspectives of Active SiO(2)Fe(x)O(y)/ZnO Composites
por: Matusoiu, Florin, et al.
Publicado: (2022)

Synthesis and Bioinformatic Characterization of New Schiff Bases with Possible Applicability in Brain Disorders
por: Avram, Speranta, et al.
Publicado: (2021)

Model-based metabolism design: constraints for kinetic and stoichiometric models
por: Stalidzans, Egils, et al.
Publicado: (2018)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi, Taro, et al.
Publicado: (2017)

Effect of Escitalopram on White Blood Cells in Patients With Major Depression
por: Canan, Fatih, et al.
Publicado: (2009)

Performance of Zr-Based Metal–Organic Framework Materials as In Vitro Systems for the Oral Delivery of Captopril and Ibuprofen
por: Cretu, Carmen, et al.
Publicado: (2023)

Increased Biomass Yield of Lactococcus lactis by Reduced Overconsumption of Amino Acids and Increased Catalytic Activities of Enzymes
por: Adamberg, Kaarel, et al.
Publicado: (2012)

Escitalopram for the management of major depressive disorder: a review of its efficacy, safety, and patient acceptability
por: Kirino, Eiji
Publicado: (2012)

Comparing the Effects of Bupropion and Escitalopram on Excessive Internet Game Play in Patients with Major Depressive Disorder
por: Nam, Beomwoo, et al.
Publicado: (2017)

Escitalopram vs duloxetine in acute treatment of major depressive disorder: meta-analysis and systematic review
por: Maneeton, Benchalak, et al.
Publicado: (2018)

Fabrication and Characterization of Fast-Dissolving Films Containing Escitalopram/Quetiapine for the Treatment of Major Depressive Disorder
por: Alkahtani, Manal E., et al.
Publicado: (2021)

Escitalopram-induced akathisia in a patient with major depressive disorder: A rare case report
por: Arshad, Hareem, et al.
Publicado: (2022)

Tissue-Specific Oxysterols as Predictors of Antidepressant (Escitalopram) Treatment Response in Patients With Major Depressive Disorder
por: Sun, Zuoli, et al.
Publicado: (2023)

Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertraline
por: Huang, Jia, et al.
Publicado: (2018)

Resting state functional connectivity patterns as biomarkers of treatment response to escitalopram in patients with major depressive disorder
por: Martens, Marieke A. G., et al.
Publicado: (2021)

An Interim Analysis of a Randomized, Open-Label Study of Vilazodone, Escitalopram, or Vortioxetine for Major Depressive Disorder
por: Santi, N Simple, et al.
Publicado: (2023)

Escitalopram versus other antidepressive agents for major depressive disorder: a systematic review and meta-analysis
por: Yin, Juntao, et al.
Publicado: (2023)

Efficacy and safety of generic escitalopram (Lexacure(®)) in patients with major depressive disorder: a 6-week multicenter, randomized, rater-blinded, escitalopram-comparative, non-inferiority study
por: Jeong, Jong-Hyun, et al.
Publicado: (2015)

CYP2D6 P34S Polymorphism and Outcomes of Escitalopram Treatment in Koreans with Major Depression
por: Han, Kyu-Man, et al.
Publicado: (2013)

Factors Influencing the Antibacterial Activity of Chitosan and Chitosan Modified by Functionalization
por: Ardean, Cristina, et al.
Publicado: (2021)

Cardiovascular Risk Prediction Parameters for Better Management in Rheumatic Diseases
por: Sharma, Abhinav, et al.
Publicado: (2022)

Mild cognitive disorder and depression: treatment with combination of galantamine and escitalopram
por: Zarra, Julio, et al.
Publicado: (2010)

Escitalopram—translating molecular properties into clinical benefit: reviewing the evidence in major depression
por: Leonard, Brian, et al.
Publicado: (2010)

ABCB1 polymorphism predicts escitalopram dose needed for remission in major depression
por: Singh, A B, et al.
Publicado: (2012)

Repurposing anti-inflammatory drugs for fighting planktonic and biofilm growth. New carbazole derivatives based on the NSAID carprofen: synthesis, in silico and in vitro bioevaluation
por: Dumitrascu, Florea, et al.
Publicado: (2023)

Synthesis, Characterization and Antimicrobial Activity of Multiple Morphologies of Gold/Platinum Doped Bismuth Oxide Nanostructures
por: Ianăși, Cătălin, et al.
Publicado: (2023)

Treatment of alcohol dependence in patients with co-morbid major depressive disorder – predictors for the outcomes with memantine and escitalopram medication
por: Muhonen, Leea H, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_41v0hf5vln3sr1ujto0cp32m2p